Losartan Carboxaldehyde
CAS No. 114798-36-6
Losartan Carboxaldehyde( —— )
Catalog No. M21093 CAS No. 114798-36-6
Losartan Carboxaldehyde is an endothelial cyclooxygenase (COX)-2 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 110 | Get Quote |
|
10MG | 177 | Get Quote |
|
25MG | 385 | Get Quote |
|
50MG | 575 | Get Quote |
|
100MG | 801 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLosartan Carboxaldehyde
-
NoteResearch use only, not for human use.
-
Brief DescriptionLosartan Carboxaldehyde is an endothelial cyclooxygenase (COX)-2 inhibitor.
-
DescriptionLosartan Carboxaldehyde is an endothelial cyclooxygenase (COX)-2 inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114798-36-6
-
Formula Weight420.8
-
Molecular FormulaC22H21ClN6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (296.99 mM)
-
SMILESCCCCc1nc(Cl)c(C=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kramer C. Angiotensin II Receptor-Independent Antiinflammatory and Antiaggregatory Properties of Losartan: Role of the Active Metabolite EXP3179[J]. Circulation Research 2002 90(7):770-776.
molnova catalog
related products
-
Amtolmetin guacil
Amtolmetin guacil inhibits prostaglandin synthesis and cyclooxygenase. Amtolmetin guacil has similar NSAID properties like tolmetin with additional analgesic, antipyretic, and gastroprotective properties.
-
Lornoxicam
Lornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties.
-
Nitroflurbiprofen
Nitroflurbiprofen is a NO-releasing COX inhibitor and modulates the increased intrahepatic vascular tone in portal hypertensive cirrhotic rats.